IRINOTECAN ALPHAPHARM irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan alphapharm irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

alphapharm pty ltd - irinotecan hydrochloride trihydrate -

IRINOTECAN EBEWE Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan ebewe

sandoz pty ltd - irinotecan hydrochloride -

Camptosar Australia - English - Department of Health (Therapeutic Goods Administration)

camptosar

pfizer australia pty ltd - irinotecan hydrochloride -

DBL Irinotecan Injection Australia - English - Department of Health (Therapeutic Goods Administration)

dbl irinotecan injection

hospira australia pty ltd - irinotecan hydrochloride; irinotecan -

IRINOCCORD Australia - English - Department of Health (Therapeutic Goods Administration)

irinoccord

accord healthcare pty ltd - irinotecan hydrochloride -

IRINOTECAN ACTAVIS Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan actavis

actavis australia pty ltd - irinotecan hydrochloride -

IRINOTECAN SZ Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan sz

accord healthcare pty ltd - irinotecan hydrochloride -

Tecan Australia - English - Department of Health (Therapeutic Goods Administration)

tecan

actavis pty ltd - irinotecan hydrochloride -

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 100 mg - injection, concentrated - excipient ingredients: sodium hydroxide; lactic acid; water for injections; hydrochloric acid; sorbitol - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: water for injections; lactic acid; sorbitol; hydrochloric acid; sodium hydroxide - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.